Background: The occurrence of multiple sclerosis (MS) increases in populations featuring both high and low disease burden, and variations across regions at the same latitude are reported. MS epidemiological data in Eastern Europe are scarce and out of date. We report on sex- and age-specific prevalence of MS in the Republic of Moldova. Methods: Benefitting from a nationwide survey aimed to quantify the MS burden in Moldovans (3,559,541 population in 2012), multiple epidemiological sources were scrutinized. Results: On prevalence day, December 31, 2012, 747 MS patients (McDonald criteria) resided in the study area, yielding a crude prevalence of 20.9 per 100,000 (95% CI 14.7-27.1), 25.7 (95% CI 20.5-30.5) in women and 15.8 (95% CI 12.2-19.3) in men (F:M ratio of 1.63), and standardized estimates of 20.2, 24.3 and 15.5 per 100,000, respectively. Prevalence was highest in the age group 40-49 years (43.9 per 100,000) and higher in rural (72.6%) than in urban (27.4%) areas. Conclusions: This is the first report on sex- and age-specific prevalence of MS in the Republic of Moldova, which was lower than in Europe on average, but consistent with that of neighboring countries, Romania and Ukraine. Moldovans represent a population wherein MS natural history is not yet influenced by use of disease-modifying drugs.

Keywords:
Multiple sclerosis, Epidemiology, Prevalence, Republic of Moldova
1.
Compston A, Wekerle H, McDonald I: The origin of multiple sclerosis: a synthesis; in Compston A (ed): McAlpine's Multiple Sclerosis, ed 4. New York, Churchill Livingstone, 2006, pp 273-284.
2.
Koch-Henriksen N, Sørensen PS: The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520-532.
3.
Koch-Henriksen N, Sorensen PS: Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere? J Neurol Sci 2011;311:58-63.
4.
Pugliatti M, Sotgiu S, Rosati G: The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002;104:182-191.
5.
Rosati G: Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview. Ann Neurol 1994;36(suppl 2):S164-S174.
6.
Rosati G: The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001;22:117-139.
7.
Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vécsei L, et al: The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006;13:700-722.
8.
Millefiorini E, Cortese A, Di Rezze S, Barletta G, Bellantonio P, Batocchi AP, et al: The prevalence of multiple sclerosis in central Italy. Mult Scler 2010;16:1432-1436.
9.
Boiko AN: Multiple sclerosis prevalence in Russia and other countries of the former USSR; in Firnhaber W, Lauer K (eds): Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt, Leuchtturm-Verlag/LTV Press, 1994, pp 219-230.
10.
Trendafilova L, Manova M, Hadjipetrova K: Multiple sclerosis in the Plovdiv area, Bulgaria; in Firnhaber W, Lauer K (eds): Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt, Leuchtturm-Verlag/LTV Press, 1994, pp 326-331.
11.
Milanov I, Georgiev D, Kmetska K, Jordanova L, Topalov N: Prevalence of multiple sclerosis in Bulgaria. Neuroepidemiology 1997;16:304-307.
12.
Milanov I, Topalov N, Kmetski T: Prevalence of multiple sclerosis in Gypsies and Bulgarians. Neuroepidemiology 1999;18:218-222.
13.
Jedlicka P: Epidemiology of multiple sclerosis in Czechoslovakia; in Battaglia MA, Crimi G (eds): An Update on Multiple Sclerosis. Bologna, Monduzzi Editore, 1989, pp 253-255.
14.
Jedlicka P, Benes B, Hron B, et al: Epidemiology of multiple sclerosis in the Czech Republic; in Firnhaber W, Lauer K (eds): Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt, Leuchtturm-Verlag/LTV Press, 1994, pp 261-265.
15.
Lensky P: Geographic disproportion of multiple sclerosis in Czechoslovakia from the point of view of indirect proof; in Firnhaber W, Lauer K (eds): Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt, Leuchtturm-Verlag/LTV Press, 1994, pp 266-273.
16.
Guseo A, Jofeiü E, Kocsis A: Epidemiology of multiple sclerosis in Western Hungary 1957-1992; in Firnhaber W, Lauer K (eds): Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt, Leuchtturm-Verlag/LTV Press, 1994, pp 279-286.
17.
Palffy G, Czopf J, Kuntar L, Gyodi E: Multiple sclerosis in Baranya County in Hungarians and in Gipsies; in Firnhaber W, Lauer K (eds): Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt, Leuchtturm-Verlag/LTV Press, 1994, pp 274-278.
18.
Bencsik K, Rajda C, Klivényi P, Klivényi P, Járdánházy T, Vécsei L: The prevalence of multiple sclerosis in the Hungarian city of Szeged. Acta Neurol Scand 1998;97:315-319.
19.
Bencsik K, Rajda C, Füvesi J, Klivényi P, Járdánházy T, Török M, et al: The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrád County, Hungary. Eur Neurol 2001;46:206-209.
20.
Wender M, Pruchnik-Grabowska D, Hertmanowska H, et al: Epidemiology of multiple sclerosis in Western Poland - a comparison between prevalence rates in 1965 and 1981. Acta Neurol Scand 1985;72:210-217.
21.
Potemkowski A, Walczak A, Nocon D, Fabian A, Nowacki P: Epidemiological analysis of multiple sclerosisin the Szczecin Region, north-western part of Poland; in Firnhaber W, Lauer K (eds): Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt, Leuchtturm-Verlag/LTV Press, 1994, pp 249-254.
22.
Potemkowski A: [Epidemiology of multiple sclerosis in the region of Szczecin: prevalence and incidence 1993-1995]. Neurol Neurochir Pol 1999;33:575-585.
23.
Petrescu A, Verdeş F: Epidemiology of multiple sclerosis in Romania. Neurol Psychiatr (Bucur) 1989;27:261-271.
24.
Petrescu A: Epidemiology of multiple sclerosis in Romania; in Firnhaber W, Lauer K (eds): Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt, Leuchtturm-Verlag/LTV Press, 1994, pp 287-293.
25.
Becuş T, Popoviciu L: Epidemiologic survey of multiple sclerosis in Mureş County, Romania. Rom J Neurol Psychiatry 1994;32:115-122.
26.
Balasa R, Feier C, Dan M, Motataianu A, Balaianu M, Chebut C, et al: The prevalence of multiple sclerosis in Mures County, Central Romania. Rev Rom Neurol 2007;VI:80-84.
27.
Boiko A, Zavalishin IA, Spirin NN, et al: Epidemiology of MS in Russia: first data of united study of multiple sclerosis epidemiology in Russia. Mult Scler 2004;10(suppl 2):157.
28.
Korbut AL, Korniychuk AG: MS in the population of Vinnytsya city central Ukraine. Neurol Neurochir Pol 2001;(suppl 2):1-60.
29.
Korniychuk AG, Zheliba OV: Epidemiology of MS in Vinnytsia Oblast, South-West Ukraine. J Neuroimmunol 2005;56-63(suppl 1):41.
30.
Kovtiukh LP: [Genetic structure of the residents of central Moldova]. Genetika 1995;31:250-258.
31.
StatBank: Number of Population (online). www.statistica.md (accessed June 13, 2014).
32.
Encyclopaedia Britannica (online). www.britannica.com/place/Moldova (accessed December 26, 2015).
33.
Cavalli-Sforza LL, Menozzi P, Piazza A: The History and Geography of Human Genes. Princeton University Press, 1994, pp 187-447.
34.
Novembre J, Stephens M: Interpreting principal component analyses of spatial population genetic variation. Nat Genet 2008;40:646-649.
35.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
36.
Poser CM: Onset symptoms of multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;58:253-254.
37.
Lublin FD, Reingold SC: Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 1996;46:907-911.
38.
Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1552.
39.
United Nations Economic Commission for Europe (UNECE). Statistical Database 2012. w3.unece.org/pxweb/dialog/varval.asp?ma=001_GEPOAGESEX_REG_r&path=/database/STAT/30-GE/01-Pop/ (accessed July 7, 2014).
40.
Multiple Sclerosis International Federation (MSIF). The Atlas of MS. www.msif.org/about-us/advocacy/atlas/ (accessed July 7, 2014).
41.
European Multiple Sclerosis Platform (EMSP). MS Barometer 2013. Widespread Health Inequalities Revealed. www.emsp.org (accessed December 26, 2015).
42.
Granieri E, Casetta I, Govoni V, Tola MR, Marchi D, Murgia SB, et al: The increasing incidence and prevalence of MS in a Sardinian province. Neurology 2000;55:842-847.
43.
Pugliatti M, Sotgiu S, Solinas G, Castiglia P, Pirastru MI, Murgia B, et al: Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk. Acta Neurol Scand 2001;103:20-26.
44.
Conradi S, Malzahn U, Schröter F, Paul F, Quill S, Spruth E, et al: Environmental factors in early childhood are associated with multiple sclerosis: a case-control study. BMC Neurol 2011;11:123.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.